SG10201901453PA - Synthetic oplophorus luciferases with enhanced light output - Google Patents
Synthetic oplophorus luciferases with enhanced light outputInfo
- Publication number
- SG10201901453PA SG10201901453PA SG10201901453PA SG10201901453PA SG10201901453PA SG 10201901453P A SG10201901453P A SG 10201901453PA SG 10201901453P A SG10201901453P A SG 10201901453PA SG 10201901453P A SG10201901453P A SG 10201901453PA SG 10201901453P A SG10201901453P A SG 10201901453PA
- Authority
- SG
- Singapore
- Prior art keywords
- light output
- enhanced
- luciferase
- wild
- amino acid
- Prior art date
Links
- 108060001084 Luciferase Proteins 0.000 title abstract 8
- 241001443978 Oplophorus Species 0.000 title abstract 5
- 239000005089 Luciferase Substances 0.000 abstract 6
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 238000004020 luminiscence type Methods 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/66—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving luciferase
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y113/00—Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13)
- C12Y113/12—Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13) with incorporation of one atom of oxygen (internal monooxygenases or internal mixed function oxidases)(1.13.12)
- C12Y113/12007—Photinus-luciferin 4-monooxygenase (ATP-hydrolysing) (1.13.12.7), i.e. firefly-luciferase
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
SYNTHETIC OPLOPHORUS LUCIFERASES WITH ENHANCED LIGHT OUTPUT A polynucleotide encoding a modified luciferase polypeptide. The modified luciferase polypeptide has at least 60% amino acid sequence identity to a wild-type Oplophorus luciferase and includes at least one amino acid substitution at a position corresponding to an amino acid in a wild-type Oplophorus luciferase of SEQ ID NO:1. The modified luciferase polypeptide has at least one of enhanced luminescence, enhanced signal stability, and enhanced protein stability relative to the wild-type Oplophorus luciferase. Fig. 8
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17483809P | 2009-05-01 | 2009-05-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201901453PA true SG10201901453PA (en) | 2019-03-28 |
Family
ID=42358981
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201901453PA SG10201901453PA (en) | 2009-05-01 | 2010-05-03 | Synthetic oplophorus luciferases with enhanced light output |
| SG2011074242A SG175180A1 (en) | 2009-05-01 | 2010-05-03 | Synthetic oplophorus luciferases with enhanced light output |
| SG10201601281WA SG10201601281WA (en) | 2009-05-01 | 2010-05-03 | Synthetic oplophorus luciferases with enhanced light output |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2011074242A SG175180A1 (en) | 2009-05-01 | 2010-05-03 | Synthetic oplophorus luciferases with enhanced light output |
| SG10201601281WA SG10201601281WA (en) | 2009-05-01 | 2010-05-03 | Synthetic oplophorus luciferases with enhanced light output |
Country Status (16)
| Country | Link |
|---|---|
| US (7) | US8557970B2 (en) |
| EP (5) | EP3409764B1 (en) |
| JP (2) | JP6038649B2 (en) |
| KR (1) | KR101665352B1 (en) |
| CN (2) | CN108192950B (en) |
| AU (1) | AU2010242771B2 (en) |
| BR (1) | BRPI1010019B1 (en) |
| CA (1) | CA2758572A1 (en) |
| DK (4) | DK2456864T3 (en) |
| ES (4) | ES2691539T3 (en) |
| IL (3) | IL215697B (en) |
| LT (1) | LT3409764T (en) |
| PL (4) | PL3409764T3 (en) |
| PT (4) | PT2456864E (en) |
| SG (3) | SG10201901453PA (en) |
| WO (1) | WO2010127368A1 (en) |
Families Citing this family (70)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3409764T3 (en) | 2009-05-01 | 2020-07-13 | Promega Corporation | Synthetic oplophorus luciferases with enhanced light output |
| CA2817102C (en) | 2010-11-02 | 2020-07-28 | Promega Corporation | Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of use |
| CN103180324A (en) | 2010-11-02 | 2013-06-26 | 普罗美加公司 | Coelenterazine derivatives and methods of using same |
| JP5896679B2 (en) * | 2011-03-15 | 2016-03-30 | オリンパス株式会社 | Large-scaled firefly luciferase |
| JP6522339B2 (en) | 2011-11-21 | 2019-05-29 | プロメガ コーポレイションＰｒｏｍｅｇａ Ｃｏｒｐｏｒａｔｉｏｎ | Carboxy X Rhodamine Analogue |
| CN104245961B (en) | 2012-02-21 | 2017-05-10 | 美国控股实验室公司 | Methods and systems for detection of microorganisms |
| US10519483B2 (en) | 2012-02-21 | 2019-12-31 | Laboratory Corporation Of America Holdings | Methods and systems for rapid detection of microorganisms using infectious agents |
| JP2015530114A (en) | 2012-09-26 | 2015-10-15 | プロメガ コーポレイションＰｒｏｍｅｇａ Ｃｏｒｐｏｒａｔｉｏｎ | Real-time monitoring |
| US10067149B2 (en) | 2012-12-12 | 2018-09-04 | Promega Corporation | Recognition of cellular target binding by a bioactive agent using intracellular bioluminescence resonance energy transfer |
| SG11201504520XA (en) | 2012-12-12 | 2015-07-30 | Promega Corp | Compositions and methods for capture of cellular targets of bioactive agents |
| KR102150479B1 (en) * | 2012-12-12 | 2020-09-01 | 프로메가 코포레이션 | Recognition of cellular target binding by a bioactive agent using intracellular bioluminescence resonance energy transfer |
| JP6511720B2 (en) * | 2013-02-28 | 2019-05-15 | Jnc株式会社 | Codon optimized mutant shrimp luciferase gene and method of using the same |
| US10168323B2 (en) * | 2013-03-15 | 2019-01-01 | Promega Corporation | Compositions and methods for capture of cellular targets of bioactive agents |
| EP2969435B1 (en) | 2013-03-15 | 2021-11-03 | Promega Corporation | Substrates for covalent tethering of proteins to functional groups or solid surfaces |
| BR112015023394B8 (en) | 2013-03-15 | 2023-09-26 | Promega Corp | Bioluminescent system and complex |
| EP2978857A2 (en) | 2013-03-27 | 2016-02-03 | Sample Technologies, Inc. | Recombinant phage and bacterial detection methods |
| JP6040846B2 (en) | 2013-04-08 | 2016-12-07 | Jnc株式会社 | Coelenterazine analog |
| WO2014205221A2 (en) | 2013-06-19 | 2014-12-24 | Sample6 Technologies, Inc. | Phage-based bacterial detection assay |
| JP6484987B2 (en) * | 2013-10-21 | 2019-03-20 | Jnc株式会社 | Evil luciferase catalytic protein mutant gene and its usage |
| JP6442825B2 (en) | 2013-12-26 | 2018-12-26 | Jnc株式会社 | Evil luciferase catalytic protein mutant gene and its usage |
| WO2015116806A1 (en) | 2014-01-29 | 2015-08-06 | Promega Corporation | Pro-substrates for live cell applications |
| WO2015116867A1 (en) | 2014-01-29 | 2015-08-06 | Promega Corporation | Quinone-masked probes as labeling reagents for cell uptake measurements |
| JP6256118B2 (en) | 2014-03-11 | 2018-01-10 | Jnc株式会社 | Chimeric gene of Evil luciferase catalytic protein and use thereof |
| JP6265020B2 (en) * | 2014-04-16 | 2018-01-24 | Jnc株式会社 | Evil luciferase catalytic protein mutant gene and its usage |
| EP3191600A1 (en) | 2014-09-11 | 2017-07-19 | Promega Corporation | Luciferase sequences utilizing infrared-emitting substrates to produce enhanced luminescence |
| US11365402B2 (en) | 2014-09-12 | 2022-06-21 | Promega Corporation | Internal protein tags |
| US9969991B2 (en) | 2014-09-12 | 2018-05-15 | Promega Corporation | Internal protein tags |
| WO2016127100A1 (en) * | 2015-02-05 | 2016-08-11 | Promega Corporation | Luciferase-based thermal shift assays |
| US10618907B2 (en) | 2015-06-05 | 2020-04-14 | Promega Corporation | Cell-permeable, cell-compatible, and cleavable linkers for covalent tethering of functional elements |
| CN107922428B (en) | 2015-06-25 | 2021-02-05 | 普洛麦格公司 | Thienopyrrole compounds and their use as inhibitors of oplophorus-derived luciferase |
| EP3510035B1 (en) | 2016-09-09 | 2021-04-07 | Promega Corporation | Dual protected pro-coelenterazine substrates |
| US11307205B2 (en) | 2016-09-19 | 2022-04-19 | University Of Southern California | Non-radioactive cytotoxicity assays |
| PL3529616T3 (en) | 2016-10-20 | 2024-03-18 | President And Fellows Of Harvard College | In vitro and cell based assays for measuring the activity of botulinum neurotoxins |
| JP7200102B2 (en) | 2016-11-01 | 2023-01-06 | プロメガ コーポレイション | Coelenterazine analogs tethered to energy acceptors |
| EP3548492B1 (en) | 2016-12-01 | 2023-07-05 | Promega Corporation | Cell impermeable coelenterazine analogues |
| US10815247B2 (en) | 2016-12-28 | 2020-10-27 | Promega Corporation | Functionalized NANOLUC inhibitors |
| EP3701014A1 (en) | 2017-10-25 | 2020-09-02 | Roche Diagnostics GmbH | Improved modified/mutant bacterial luciferases |
| US20200393446A1 (en) | 2017-12-08 | 2020-12-17 | Centre National De La Recherche Scientifique (Cnrs) | Bioluminescent screening test for detecting cell cytolysis |
| CN111886345B (en) | 2018-03-30 | 2023-09-15 | 英威达纺织（英国）有限公司 | High hydrogen utilization and gas recirculation |
| US10975363B2 (en) * | 2018-03-30 | 2021-04-13 | Inv Nylon Chemicals Americas, Llc | Materials and methods for biosynthetic manufacture and utilization of synthetic polypeptides, and products therefrom |
| US11655247B2 (en) | 2018-05-01 | 2023-05-23 | Promega Corporation | Nanoluc suicide substrates |
| US11702680B2 (en) | 2018-05-02 | 2023-07-18 | Inv Nylon Chemicals Americas, Llc | Materials and methods for controlling PHA biosynthesis in PHA-generating species of the genera Ralstonia or Cupriavidus and organisms related thereto |
| EP3788148A1 (en) | 2018-05-02 | 2021-03-10 | INVISTA Textiles (U.K.) Limited | Materials and methods for maximizing biosynthesis through alteration of pyruvate-acetyl-coa-tca balance in species of the genera ralstonia and cupriavidus and organisms related thereto |
| JP7432529B2 (en) | 2018-05-30 | 2024-02-16 | プロメガ コーポレイション | Broad Spectrum Kinase Binders |
| WO2019232384A1 (en) | 2018-06-01 | 2019-12-05 | Promega Corporation | Inhibitors of oplophorus luciferase-derived bioluminescent complexes |
| US10962538B2 (en) | 2018-06-14 | 2021-03-30 | The Trustees Of Columbia University In The City Of New York | Assays using arrestin recruitment and unmodified receptors |
| EP3861128A2 (en) | 2018-10-03 | 2021-08-11 | Promega Corporation | Compositions and methods for stabilizing coelenterazine and analogs and derivatives thereof |
| US11175228B2 (en) | 2018-11-28 | 2021-11-16 | Promega Corporation | Reactive peptide labeling |
| EP3891503A2 (en) | 2018-12-04 | 2021-10-13 | Promega Corporation | Broad spectrum gpcr binding agents |
| EP3941195A4 (en) | 2019-03-20 | 2023-03-22 | Promega Corporation | Photoaffinity probes |
| US11360096B2 (en) | 2019-05-16 | 2022-06-14 | Duke University | Complex BRET technique for measuring biological interactions |
| CA3140294A1 (en) | 2019-06-21 | 2020-12-24 | Jose S. GIL | Methods for producing mutant bacteriophages for the detection of listeria |
| JP2022539343A (en) | 2019-06-24 | 2022-09-08 | プロメガ コーポレイション | Modified polyamine polymers for delivery of biomolecules into cells |
| MX2022002430A (en) | 2019-08-26 | 2022-03-22 | Laboratory Corp America Holdings | Devices and methods for detecting microorganisms using recombinant reproduction-deficient indicator bacteriophage. |
| MX2022003092A (en) | 2019-09-11 | 2022-06-08 | Laboratory Corp America Holdings | Methods and systems for the rapid detection of microorganisms using recombinant infectious agents to express an indicator subunit. |
| EP4065699A1 (en) | 2019-11-27 | 2022-10-05 | Promega Corporation | Multipartite luciferase peptides and polypeptides |
| US12061202B2 (en) | 2019-12-10 | 2024-08-13 | Promega Corporation | Compositions and methods for bioluminescent detection using multifunctional probes |
| EP4096691A1 (en) | 2020-01-28 | 2022-12-07 | Freeline Therapeutics Limited | Improved assay for determining neutralising antibody titre to a viral vektor |
| EP4153770A2 (en) | 2020-05-22 | 2023-03-29 | Promega Corporation | Enhancement of kinase target engagement |
| JP2023540934A (en) | 2020-08-28 | 2023-09-27 | プロメガ コーポレイション | RAS protein target engagement assay |
| KR20230124938A (en) | 2020-12-25 | 2023-08-28 | 추가이 세이야쿠 가부시키가이샤 | Method for screening candidate molecules capable of forming complexes with a plurality of target molecules |
| CN115161296B (en) * | 2021-04-01 | 2024-08-13 | 深圳华大生命科学研究院 | Mutant of spiny shrimp luciferase Nluc and application thereof |
| CN113025586B (en) * | 2021-04-06 | 2022-10-04 | 湖北省中医院 | Modified luciferase mutant protein, bioluminescent probe, probe set, preparation method and detection method |
| US20240174992A1 (en) | 2022-05-04 | 2024-05-30 | Promega Corporation | Split modified dehalogenase variants |
| WO2023215432A1 (en) | 2022-05-04 | 2023-11-09 | Promega Corporation | Circularly permuted dehalogenase variants |
| WO2023215514A2 (en) | 2022-05-04 | 2023-11-09 | Promega Corporation | Bioluminescence-triggered photocatalytic labeling |
| US20240132859A1 (en) | 2022-05-04 | 2024-04-25 | Promega Corporation | Modified dehalogenase with extended surface loop regions |
| GB202213479D0 (en) | 2022-09-14 | 2022-10-26 | Ipsen Biopharm Ltd | Cell-free clostridial neurotoxin assays |
| WO2024059832A1 (en) * | 2022-09-15 | 2024-03-21 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for assessing kinase activity |
| GB202404021D0 (en) | 2024-03-20 | 2024-05-01 | Ipsen Biopharm Ltd | Cell-based neurotoxin assay |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8911957D0 (en) | 1989-05-24 | 1989-07-12 | Interox Chemicals Ltd | Peroxyacid manufacture |
| US5368484A (en) | 1992-05-22 | 1994-11-29 | Atari Games Corp. | Vehicle simulator with realistic operating feedback |
| AU698424C (en) * | 1994-01-03 | 2002-10-10 | Promega Corporation | Mutant luciferases |
| WO1999014336A2 (en) | 1997-09-19 | 1999-03-25 | Promega Corporation | Thermostable luciferases and methods of production |
| JP3694181B2 (en) | 1999-01-05 | 2005-09-14 | キッコーマン株式会社 | Mutant luciferase, mutant luciferase gene, novel recombinant DNA and method for producing mutant luciferase |
| NZ518413A (en) | 1999-10-26 | 2004-11-26 | Secr Defence | Novel enzyme |
| DE60142761D1 (en) * | 2000-04-26 | 2010-09-23 | Chisso Corp | Oplophorus luciferase |
| JP4613441B2 (en) * | 2000-04-26 | 2011-01-19 | チッソ株式会社 | Novel luciferase and photoprotein |
| US7118878B1 (en) | 2000-06-09 | 2006-10-10 | Promega Corporation | Method for increasing luminescence assay sensitivity |
| US7268229B2 (en) | 2001-11-02 | 2007-09-11 | Promega Corporation | Compounds to co-localize luminophores with luminescent proteins |
| EP2433871A3 (en) | 2002-06-19 | 2012-07-11 | Medical Instill Technologies, Inc. | Sterile filling machine having needle filling station within e-beam chamber |
| AU2005230854A1 (en) * | 2004-03-31 | 2005-10-20 | Xencor, Inc | BMP-7 variants with improved properties |
| JP3844082B2 (en) * | 2005-04-08 | 2006-11-08 | キッコーマン株式会社 | Thermostable firefly luciferase, thermostable firefly luciferase gene, novel recombinant DNA, and method for producing thermostable firefly luciferase |
| JP4999341B2 (en) * | 2005-09-06 | 2012-08-15 | 株式会社バイオエネックス | Mutant firefly luciferase, gene, recombinant vector, transformant, and method for producing mutant firefly luciferase |
| CA2648263A1 (en) * | 2006-04-03 | 2007-10-25 | Promega Corporation | Permuted and nonpermuted luciferase biosensors |
| WO2008118445A1 (en) * | 2007-03-26 | 2008-10-02 | Promega Corporation | Methods to quench light from optical reactions |
| EP2215227A2 (en) * | 2007-11-05 | 2010-08-11 | Promega Corporation | Hybrid fusion reporter and uses thereof |
| US9045730B2 (en) * | 2008-05-19 | 2015-06-02 | Promega Corporation | Luciferase biosensors for cAMP |
| JPWO2010119721A1 (en) | 2009-04-17 | 2012-10-22 | 独立行政法人産業技術総合研究所 | Ultra-bright and stable artificial bioluminescent enzyme |
| PL3409764T3 (en) | 2009-05-01 | 2020-07-13 | Promega Corporation | Synthetic oplophorus luciferases with enhanced light output |
| CA2817102C (en) * | 2010-11-02 | 2020-07-28 | Promega Corporation | Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of use |
-
2010
- 2010-05-03 PL PL18184699T patent/PL3409764T3/en unknown
- 2010-05-03 DK DK10717013.6T patent/DK2456864T3/en active
- 2010-05-03 EP EP18184699.9A patent/EP3409764B1/en active Active
- 2010-05-03 EP EP20169057.5A patent/EP3744834A1/en active Pending
- 2010-05-03 BR BRPI1010019A patent/BRPI1010019B1/en active IP Right Grant
- 2010-05-03 WO PCT/US2010/033449 patent/WO2010127368A1/en active Application Filing
- 2010-05-03 PL PL17154777T patent/PL3181687T3/en unknown
- 2010-05-03 US US12/773,002 patent/US8557970B2/en active Active
- 2010-05-03 AU AU2010242771A patent/AU2010242771B2/en active Active
- 2010-05-03 EP EP15186652.2A patent/EP2990478B1/en active Active
- 2010-05-03 EP EP10717013.6A patent/EP2456864B1/en active Active
- 2010-05-03 ES ES17154777T patent/ES2691539T3/en active Active
- 2010-05-03 CN CN201810043641.3A patent/CN108192950B/en active Active
- 2010-05-03 SG SG10201901453PA patent/SG10201901453PA/en unknown
- 2010-05-03 LT LTEP18184699.9T patent/LT3409764T/en unknown
- 2010-05-03 SG SG2011074242A patent/SG175180A1/en unknown
- 2010-05-03 CA CA2758572A patent/CA2758572A1/en active Pending
- 2010-05-03 DK DK18184699.9T patent/DK3409764T3/en active
- 2010-05-03 ES ES10717013.6T patent/ES2559505T3/en active Active
- 2010-05-03 PT PT107170136T patent/PT2456864E/en unknown
- 2010-05-03 KR KR1020117028749A patent/KR101665352B1/en active IP Right Grant
- 2010-05-03 JP JP2012508822A patent/JP6038649B2/en active Active
- 2010-05-03 CN CN201080019477.4A patent/CN102459579B/en active Active
- 2010-05-03 PL PL15186652T patent/PL2990478T3/en unknown
- 2010-05-03 PT PT181846999T patent/PT3409764T/en unknown
- 2010-05-03 EP EP17154777.1A patent/EP3181687B1/en active Active
- 2010-05-03 ES ES15186652.2T patent/ES2629390T3/en active Active
- 2010-05-03 DK DK15186652.2T patent/DK2990478T3/en active
- 2010-05-03 DK DK17154777.1T patent/DK3181687T3/en active
- 2010-05-03 PL PL10717013T patent/PL2456864T3/en unknown
- 2010-05-03 SG SG10201601281WA patent/SG10201601281WA/en unknown
- 2010-05-03 PT PT17154777T patent/PT3181687T/en unknown
- 2010-05-03 ES ES18184699T patent/ES2795287T3/en active Active
- 2010-05-03 PT PT151866522T patent/PT2990478T/en unknown
-
2011
- 2011-10-11 IL IL215697A patent/IL215697B/en active IP Right Grant
-
2013
- 2013-10-14 US US14/053,252 patent/US9777311B2/en active Active
-
2015
- 2015-10-22 JP JP2015208321A patent/JP6227615B2/en active Active
-
2017
- 2017-09-25 US US15/714,210 patent/US10233485B2/en active Active
-
2019
- 2019-03-06 US US16/294,464 patent/US10633690B2/en active Active
- 2019-03-10 IL IL265263A patent/IL265263B/en active IP Right Grant
-
2020
- 2020-03-17 US US16/821,682 patent/US10844422B2/en active Active
- 2020-04-22 IL IL274145A patent/IL274145B/en unknown
- 2020-10-20 US US17/075,415 patent/US11365436B2/en active Active
-
2022
- 2022-06-20 US US17/844,371 patent/US11667950B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG10201901453PA (en) | Synthetic oplophorus luciferases with enhanced light output | |
| CA2817102A1 (en) | Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of use | |
| CA3081446A1 (en) | Methods and compositions for polypeptide analysis | |
| MX2014011459A (en) | Charged nutritive proteins and methods. | |
| MX2013012844A (en) | Amino acid sequences directed against il-17a, il-17f and/or il17-a/f and polypeptides comprising the same. | |
| EA201000327A1 (en) | PROTEIN | |
| EA201070270A1 (en) | PEPTIDES WITH REDUCED LEVEL OF FORMATION OF DIMERS | |
| NZ707439A (en) | Modified factor ix polypeptides and uses thereof | |
| EA201170879A1 (en) | POLYPEPTIDES WITH XYLANASE ACTIVITY | |
| EA201401211A1 (en) | IMPROVED CHIMOZIN ENZYME OPTIONS | |
| MY160552A (en) | Low protein infant formula with increased essential amino acids | |
| NZ595496A (en) | Cellulolytic enzymes, nucleic acids encoding them and methods for making and using them | |
| NZ591855A (en) | Novel immunotherapy against several tumors including neuronal and brain tumors | |
| MX340498B (en) | Heterodimerized polypeptide. | |
| EP2507267A4 (en) | Compositions and methods for increasing serum half-life of fc fusion proteins | |
| MX2020011083A (en) | Protein. | |
| NZ609216A (en) | Anticancer fusion protein | |
| NZ706884A (en) | Fc gamma receptor iib variants | |
| SG10201902596TA (en) | Novel methods of protein evolution | |
| MX2011004483A (en) | Leukolectins and uses thereof. | |
| EA201691011A1 (en) | SEQUENCE OF MODIFIED ENDOLYSINE EL188 | |
| MX2016006277A (en) | Modified kz144 endolysin sequence. | |
| NZ734705A (en) | Herbicide resistance protein, and encoding genes and application thereof | |
| MX2015009867A (en) | Factor x mutants. | |
| MY160224A (en) | Signal peptide contained in mannose-specific lectin precursor, nucleic acid encoding the signal peptide, and use of the signal peptide and the nucleic acid |